The cardiac toxicity of PAMAM dendrimer drug delivery systems can be attenuated with the adjunct use of cardioprotective agents. Biomol Biomed [Internet]. 2025 Mar. 7 [cited 2025 Apr. 4];25(4):914–924. Available from: https://www.bjbms.org/ojs/index.php/bjbms/article/view/10735